These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 21838483

  • 1. Combined liver-kidney transplantation in familial amyloidotic polyneuropathy TTR V30M: nephrological assessment.
    Lobato L, Beirão I, Seca R, Pessegueiro H, Rocha MJ, Queiroz J, Gomes M, Henriques AC, Teixeira M, Almeida R.
    Amyloid; 2011 Jun; 18 Suppl 1():190-2. PubMed ID: 21838483
    [No Abstract] [Full Text] [Related]

  • 2. Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry.
    Herlenius G, Wilczek HE, Larsson M, Ericzon BG, Familial Amyloidotic Polyneuropathy World Transplant Registry.
    Transplantation; 2004 Jan 15; 77(1):64-71. PubMed ID: 14724437
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Impact of liver transplantation on the natural history of oculopathy in Portuguese patients with transthyretin (V30M) amyloidosis.
    Beirão JM, Malheiro J, Lemos C, Matos E, Beirão I, Pinho-Costa P, Torres P.
    Amyloid; 2015 Mar 15; 22(1):31-5. PubMed ID: 25475560
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Transthyretin-related familial amyloidotic polyneuropathy.
    Ando Y, Nakamura M, Araki S.
    Arch Neurol; 2005 Jul 15; 62(7):1057-62. PubMed ID: 16009758
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Model for end-stage liver disease (MELD) exception for familial amyloidotic polyneuropathy.
    Pomfret E, Gish RG, Brandhagen D.
    Liver Transpl; 2006 Dec 15; 12(12 Suppl 3):S100-1. PubMed ID: 17123281
    [No Abstract] [Full Text] [Related]

  • 9. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
    Ando Y, Terazaki H, Nakamura M, Ando E, Haraoka K, Yamashita T, Ueda M, Okabe H, Sasaki Y, Tanihara H, Uchino M, Inomata Y.
    Transplantation; 2004 Feb 15; 77(3):345-9. PubMed ID: 14966406
    [Abstract] [Full Text] [Related]

  • 10. Report from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR) and the Domino Liver Transplant Registry (DLTR).
    Ericzon BG, Larsson M, Herlenius G, Wilczek HE, Familial Amyloidotic Polyneuropathy World Transplant Registry.
    Amyloid; 2003 Aug 15; 10 Suppl 1():67-76. PubMed ID: 14640044
    [Abstract] [Full Text] [Related]

  • 11. Severe congestive heart failure with cardiac liver cirrhosis 10 years after orthotopic liver transplantation for familial amyloidotic polyneuropathy.
    Sakashita N, Ando Y, Haraoka K, Terazaki H, Yamashita T, Nakamura M, Takeya M.
    Pathol Int; 2006 Jul 15; 56(7):408-12. PubMed ID: 16792551
    [Abstract] [Full Text] [Related]

  • 12. The inflammatory response to sciatic nerve injury in a familial amyloidotic polyneuropathy mouse model.
    Gonçalves NP, Teixeira-Coelho M, Saraiva MJ.
    Exp Neurol; 2014 Jul 15; 257():76-87. PubMed ID: 24800914
    [Abstract] [Full Text] [Related]

  • 13. TTR-familial amyloid polyneuropathy--neurological aspects.
    Said G, Planté-Bordeneuve V.
    Amyloid; 2012 Jun 15; 19 Suppl 1():25-7. PubMed ID: 22620963
    [Abstract] [Full Text] [Related]

  • 14. Spatial visual contrast sensitivity in liver transplanted Portuguese familial amyloidotic polyneuropathy (ATTR V30M) patients.
    Beirão M, Matos E, Reis R, Beirão I, Costa PP, Torres P.
    Amyloid; 2012 Sep 15; 19(3):152-5. PubMed ID: 22856676
    [Abstract] [Full Text] [Related]

  • 15. [Familial amyloid polyneuropathy: liver transplantation as first-line therapy].
    Yamashita T.
    Brain Nerve; 2014 Jul 15; 66(7):763-71. PubMed ID: 24998821
    [Abstract] [Full Text] [Related]

  • 16. Long-term outcome of patients with hereditary transthyretin V30M amyloidosis with polyneuropathy after liver transplantation.
    Okumura K, Yamashita T, Masuda T, Misumi Y, Ueda A, Ueda M, Obayashi K, Jono H, Yamashita S, Inomata Y, Ando Y.
    Amyloid; 2016 Jul 15; 23(1):39-45. PubMed ID: 26763274
    [Abstract] [Full Text] [Related]

  • 17. Amyloid turnover after liver transplantation in FAP.
    Obayashi K, Ueda M, Jono H, Yamashita T, Yazaki M, Kametani F, Ohya Y, Inomata Y, Ikeda S, Ando Y.
    Amyloid; 2011 Jun 15; 18 Suppl 1():187-9. PubMed ID: 21838482
    [No Abstract] [Full Text] [Related]

  • 18. A transgenic rat with the human ATTR V30M: a novel tool for analyses of ATTR metabolisms.
    Ueda M, Ando Y, Hakamata Y, Nakamura M, Yamashita T, Obayashi K, Himeno S, Inoue S, Sato Y, Kaneko T, Takamune N, Misumi S, Shoji S, Uchino M, Kobayashi E.
    Biochem Biophys Res Commun; 2007 Jan 12; 352(2):299-304. PubMed ID: 17126291
    [Abstract] [Full Text] [Related]

  • 19. Domino liver transplantation: risks and benefits.
    Ericzon BG, Larsson M, Wilczek HE.
    Transplant Proc; 2008 May 12; 40(4):1130-1. PubMed ID: 18555132
    [Abstract] [Full Text] [Related]

  • 20. Impact of liver transplantation on familial amyloidotic polyneuropathy (FAP) patients' symptoms and complications.
    Suhr OB.
    Amyloid; 2003 Aug 12; 10 Suppl 1():77-83. PubMed ID: 14640045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.